Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DeathXray33on Nov 17, 2024 2:14pm
256 Views
Post# 36317231

RE:RE:RE:RE:RE:RE:RE:RE:First step of many big steps...

RE:RE:RE:RE:RE:RE:RE:RE:First step of many big steps...
McBullish wrote: I am interested in hearing your take on recent progress and potential. Ive been struggling to get a perspective here that isnt overly optimistic. Ive been steadily increasing my position but I am not sure exactly how much farther I am going to go.


I'm buying more tomorrow. ------------------------------------------------------------"There is a growing attraction in analyzing off-patent drugs that have established safety, pharmacokinetics (how the human body interacts with a drug) and efficacy and repurposing them for other indications; specifically, cancer, to significantly reduce the cost and time to bring them to market. Theralase has demonstrated in preclinical research that Rutherrin is able to accomplish this task with various drugs, by significantly enhancing their efficacy in the destruction of cancer cells and repurposing their use in the treatment of multiple cancer indications."
<< Previous
Bullboard Posts
Next >>